Search

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Thursday, April 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Katharine Hsu Named Director of Tri-Institutional MD-PhD Program Katharine Hsu MSK’s Katharine Hsu, MD, PhD , has been named director of the Tri-Institutional MD-PhD Program , a joint

A novel treatment for prostate cancer involves a light-sensitive drug that destroys small tumors and the blood vessels that feed them.

… Monday, September 18, 2017 Summary Treatment of prostate cancer involves the risk of complications that can reduce quality of life. MSK researchers are exploring a new technology called vascular-targeted photodynamic therapy to help alleviate this risk. It can destroy small prostate tumors with a drug

The new Evelyn H. Lauder Breast Center of Memorial Sloan Kettering Cancer Center and the Memorial Sloan Kettering Cancer Center Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection.

… Monday, October 5, 2009 The new Evelyn H. Lauder Breast Center of Memorial Sloan Kettering Cancer Center (MSKCC) and the MSKCC Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection. VIDEO | 5:00 Virtual Tour

Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.

… Wednesday, January 26, 2022 Craig B. Thompson, MD , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State ’s 2022 Health Care Power 100 list . The prestigious Health Care Power list recognizes the most influential public health officials, hospital executives

A new study from Kenneth Offit, MD, Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with advanced cancer are not detected using traditional methods based on family history.

… Tuesday, September 5, 2017 Bottom Line A new study from Kenneth Offit, MD , Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with

In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.

… Friday, April 9, 2021 Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers , has been named director of the Tri-Institutional M.D.-Ph.D. Program , a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial

When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.

… Wednesday, December 27, 2017 Summary Nobel prizes aren’t awarded posthumously — or to chickens. But a case could be made that we owe our greatest cancer discoveries to one such unassuming bird. Peyton Rous wasn’t expecting a chicken to show up in his laboratory one day in 1909. But there she was, a barred

Learn how developmental biologists at MSK solved a decades-old cellular mystery. Their findings will have an immediate and lasting impact on the understanding and treatment of ciliopathies, which cause a host of medical problems and affect 1 in 2,000 people worldwide.

… Thursday, August 28, 2025 Some might say it looks like a finger. Others might see a worm. Scientists in the field often liken it to an antenna. The technical name is primary cilium. This slender, microscopic appendage juts out from the surface of most cells in the human body — and yet for many years,

Learn about a new multiple myeloma drug that can stop the disease after other treatments have failed.

… Thursday, August 24, 2023 There is good news about  multiple myeloma , a rare blood cancer that can be difficult to treat. This month, the FDA granted accelerated approval to a drug, elranatamab (Elrexfio™) for resistant forms of the disease.  “Widespread availability of elranatamab could help improve

MSK's Dr. Larry Norton, a national breast cancer expert, discusses how artificial intelligence is helping doctors.

… Monday, June 10, 2024 Artificial intelligence (AI) technology has been in the spotlight in recent months as AI chatbots and image generators have become widespread, leading to renewed conversations about the technology’s role in medicine. One of AI’s most immediate applications for patient care is to